C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2002
12/17/2002	US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions
12/17/2002	US6495496 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions
12/17/2002	CA2064783C Cytoprotective fatty moiety compounds
12/12/2002	WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	US20020188137 Low shrinkage thermosetting resin compositions and methods of use thereof
12/12/2002	US20020188136 Pesticides and herbicides
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020187993 Bifunctional energy-reversible acyl-compositions
12/12/2002	US20020187992 Prodrugs via acylation with cinnamate
12/12/2002	DE10125882A1 Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicines containing an effector of the glutathione metabolism together with alpha-lipoic acid in the treatment of diabetes mellitus
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263849A1 Degradable cross-linking agents and cross-linked network polymers formed therewith
12/11/2002	EP1263773A1 Oligonucleotide analogues, methods of synthesis and methods of use
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263743A1 Heterocycle substituted diphenyl leukotriene antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263723A1 Ningalin b analogs employable for reversing multidrug resistance
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1058678B1 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
12/11/2002	EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002	EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384820A Process for production of N-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials
12/11/2002	CN1384743A Remedies or preventives for diseases in association with chemokines
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	USRE37936 Pesticidal 1-polyarylpyrazoles
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492541 Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use
12/10/2002	US6492534 Process and intermediate compounds for the preparation of pyrrolidines
12/10/2002	US6492523 Subjecting a pyrrole derivative, methyl aminocrotonate and 2-chlorobenzaldehyde to a hantzsch reaction, and converting the pyrrole residue of the resulting product to an amine group by the action of hydroxylamine hydrochloride.
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002	CA2036360C Reagents and methods for stereospecific fluoromethylation
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002096882A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096872A1 Substituted imidates as pesticidal agents
12/05/2002	WO2002096871A1 Allylmercaptocaptopril compounds and uses thereof
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096398A2 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus
12/05/2002	US20020183535 Metal catalysts and methods for making and using same
12/05/2002	US20020183527 Process for the preparation of amorphous atorvastatin
12/05/2002	US20020183523 Cis-substituted aminocyclopropane derivative
12/05/2002	US20020183517 Reacting dihydric alcohol characterized by four to six carbons, preferably 1,5-pentanediol, with excess ammonia in presence of ZSM-5 catalyst modified with nickel, copper or cobalt
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	US20020183378 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183303 Activity as selective serotonin re- uptake inhibitors (SSRIs); for therapy and prophylaxis of depression, attention deficit hyperactivity disorder, obsessive- compulsive disorder, post-traumatic stress disorder, sexual dysfunction
12/05/2002	DE10125963A1 Substituierte Imidate Substituted Imidates
12/05/2002	CA2449019A1 Method for treating nerve injury caused by surgery
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/04/2002	EP1261584A1 Crystalline forms of antibiotic side chain intermediates
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP0858262B1 Thrombin inhibitors
12/04/2002	CN1095463C Prepn. method of high purity N-formyl pyrrolidine and its homolog
12/03/2002	US6489515 Gas-phase dehydration reaction process
12/03/2002	US6489491 Synthesis of compounds useful in the manufacture of ketorolac
12/03/2002	US6489490 Pesticides
12/03/2002	US6489481 Compounds used for treatment and/or prevention of neuronal apoptosis and/or excitotoxicity related neurological disorders
12/03/2002	US6489480 Coordination polymerization catalyst for alpha-olefins
12/03/2002	US6489473 Pyrroloazepine derivatives
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002	WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	WO2002094748A1 Impurity inhibition in olefin metathesis reactions
11/28/2002	WO2002094311A1 Use of proteasome inhibitors to treat dry eye disorders
11/28/2002	WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002	WO2002094220A1 Liquid pharmaceutical composition

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 404